Tower Research Capital (TRC)’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $253K | Buy |
5,384
+790
| +17% | +$37.1K | 0.01% | 1574 |
|
2025
Q1 | $203K | Sell |
4,594
-4,337
| -49% | -$191K | 0.01% | 1369 |
|
2024
Q4 | $323K | Buy |
8,931
+5,097
| +133% | +$184K | 0.01% | 1356 |
|
2024
Q3 | $123K | Sell |
3,834
-6,474
| -63% | -$207K | ﹤0.01% | 2075 |
|
2024
Q2 | $388K | Buy |
10,308
+7,454
| +261% | +$281K | 0.01% | 1546 |
|
2024
Q1 | $140K | Sell |
2,854
-1,817
| -39% | -$89.4K | ﹤0.01% | 1638 |
|
2023
Q4 | $170K | Buy |
4,671
+3,470
| +289% | +$127K | ﹤0.01% | 2230 |
|
2023
Q3 | $27.8K | Sell |
1,201
-1,921
| -62% | -$44.4K | ﹤0.01% | 3084 |
|
2023
Q2 | $81.9K | Buy |
3,122
+1,222
| +64% | +$32K | ﹤0.01% | 2174 |
|
2023
Q1 | $49K | Sell |
1,900
-9,246
| -83% | -$238K | ﹤0.01% | 2518 |
|
2022
Q4 | $290K | Buy |
11,146
+8,556
| +330% | +$223K | 0.01% | 1045 |
|
2022
Q3 | $74K | Sell |
2,590
-11,493
| -82% | -$328K | ﹤0.01% | 2830 |
|
2022
Q2 | $346K | Buy |
14,083
+7,925
| +129% | +$195K | 0.01% | 1372 |
|
2022
Q1 | $347K | Buy |
6,158
+525
| +9% | +$29.6K | ﹤0.01% | 1383 |
|
2021
Q4 | $349K | Buy |
5,633
+1,901
| +51% | +$118K | 0.01% | 1370 |
|
2021
Q3 | $237K | Sell |
3,732
-726
| -16% | -$46.1K | 0.01% | 1652 |
|
2021
Q2 | $368K | Buy |
4,458
+3,628
| +437% | +$299K | 0.01% | 1434 |
|
2021
Q1 | $61K | Sell |
830
-122
| -13% | -$8.97K | ﹤0.01% | 2962 |
|
2020
Q4 | $69K | Sell |
952
-9,863
| -91% | -$715K | ﹤0.01% | 2741 |
|
2020
Q3 | $516K | Buy |
10,815
+8,445
| +356% | +$403K | 0.01% | 1648 |
|
2020
Q2 | $100K | Buy |
+2,370
| New | +$100K | ﹤0.01% | 2455 |
|
2019
Q4 | – | Sell |
-1,014
| Closed | -$22K | – | 4324 |
|
2019
Q3 | $22K | Buy |
+1,014
| New | +$22K | ﹤0.01% | 2422 |
|